New depression app should be trialled on NHS: NICE

The National Institute for Health and Care Excellence (NICE) says online and mobile programme Deprexis should be tested out in NHS services.

The programme could help around 200 adults in England with depression get faster access to care, NICE added.

Deprexis uses the principles of cognitive behavioural therapy (CBT) to help people assess their own situation and find effective ways of coping. It can be used on any device that has internet access.

NICE says Deprexis could be an effective alternative therapy for adults with mild to moderate depression.

In advice published to NHS England, NICE recommends that the therapy is trialled for up to two years in at least two of the specialist services that were set up to improve access to psychological therapies.

During the trial, people using the programme will be guided by a therapist. People can log into the programme at any time to complete modules of CBT, avoiding the need to attend therapist appointments in person.

Paul Chrisp, programme director of the medical and technologies programme at NICE, said: “Deprexis is a digital therapy that could help speed up access to care and free up therapist time to treat more people. This new programme, funded by NHS England, has meant that we can now open up access to innovative therapies by recommending them for real-world evidence study. Our aim is to provide evidence-based advice so services can make informed decisions and people have more flexible options to treat anxiety and depression.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho